autologous dendritic cell vaccine (Beijing TIL Therapeutics)

N/A

Report date: 2025/01/26 19:35:52

Base Information

Drug Nameautologous dendritic cell vaccine (Beijing TIL Therapeutics)
Drug Alias NameCOVID19 s-vax loaded autologous dendritic cell (Beijing TIL Therapeutics)autologous dendritic cell vaccine (Beijing TIL Therapeutics)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing TIL Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing TIL Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A